Author: Ken Dropiewski

Abbott Receives CE Mark for Next-Generation MitraClip™ Heart Valve Repair Device to Treat Mitral Regurgitation

– CE Mark for MitraClip G4 offers physicians an innovative next-generation system with more options for mitral valve repair using proven clip-based technology – MitraClip is a first-of-its-kind transcatheter mitral valve therapy, now on its fourth generation, improving further on MitraClip’s history as a safe and effective treatment option ABBOTT […]

Boston Scientific Announces Expanded Investment and Exclusive Acquisition Option Agreement with Farapulse, Inc.

Agreement expands company’s access to pulsed field ablation technology MARLBOROUGH, Mass., Sept. 21, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced it has signed an investment agreement with an exclusive option to acquire Farapulse, Inc., a privately-held company developing a pulsed field ablation (PFA) system for the treatment of atrial fibrillation […]

ARCA biopharma Announces Submission of IND Application to U.S. FDA for AB201 as a Potential Treatment for COVID-19

WESTMINSTER, Colo., Sept. 21, 2020 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced it has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) under the Coronavirus Treatment Acceleration Program (CTAP) to evaluate AB201 […]

BIOLIFE4D Names Pharmaceutical Veteran Kate Lewis as President

Company’s first female executive to lead commercialization efforts of BIOLIFE4D’s live-saving 3D bioprinting technologies CHICAGO, Sept. 21, 2020 (GLOBE NEWSWIRE) — BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has named Kate Lewis as President of the company. She […]

AngioDynamics Announces Commercial Launch of Auryon Atherectomy System in United States

ADVANCED MEDICAL TECHNOLOGY SAFELY1 & EFFECTIVELY TREATS PAD, CLI, ISR LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced the launch of the Auryon Atherectomy System, a newly-developed innovative technology for the treatment of Peripheral […]

Acutus Medical Announces FDA Clearance of Second-Generation AcQMap 3D Imaging & Mapping Catheter

Design Features Improve Handling and Deliverability to Enhance Efficiency CARLSBAD, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) — Acutus Medical (Nasdaq: AFIB) today announces FDA 510(k) clearance of the second-generation AcQMap® 3D imaging and mapping catheter which builds on its predecessor, improving handling and deliverability. This flagship 3D mapping and navigation catheter combines […]

CardieX Granted Patent in Europe for Key Brachial Cuff Blood Pressure Technology

IRVINE, Calif., Sept. 18, 2020 /PRNewswire/ — CardieX Limited (ASX: CDX) (CardieX, the Company) announced today that CardieX subsidiary ATCOR was granted a new patent by the European Patent Office (EPO) for the Company’s proprietary SphygmoCor® technology used in cuff-based blood pressure devices. EPO Patent Number EP2566387 further protects the company’s intellectual property in […]

Prytime Medical™ Launches New ER-REBOA™ PLUS Catheter

REBOA refined. REBOA made easier. SAN ANTONIO–(BUSINESS WIRE)–Prytime Medical Devices, Inc. introduced its latest aortic occlusion catheter, the ER-REBOA™ PLUS this week at the American Association for the Surgery of Trauma (AAST) Annual Meeting. Designed for improved ease of use, it is REBOA refined for controlling massive non-compressible hemorrhage. “The […]

Compelling New Research Links Increased Omega-3 Intake to Improved Cardiovascular Outcomes

Study published in Mayo Clinic Proceedings supports multiple cardiovascular risk reductions SALT LAKE CITY, Sept. 17, 2020 /PRNewswire/ — A new study, the most comprehensive analysis of the role of omega-3 dosage on cardiovascular prevention to date, provides compelling evidence for consuming more EPA and DHA (eicosapentaenoic acid and docosahexaenoic acid, respectively) […]